These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 16516697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M, Lauri G, Melzi G, Cattadori G, Agostoni P.
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH, Jørgensen CG, Mulvany MJ, Sørensen KE.
    Blood Press; 2007 Jun; 16(2):106-13. PubMed ID: 17612909
    [Abstract] [Full Text] [Related]

  • 6. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice.
    Passantino A, Lagioia R, Mastropasqua F, Scrutinio D.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):99-105. PubMed ID: 16814655
    [Abstract] [Full Text] [Related]

  • 7. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.
    Macdonald JE, Kennedy N, Struthers AD.
    Heart; 2004 Jul 04; 90(7):765-70. PubMed ID: 15201246
    [Abstract] [Full Text] [Related]

  • 8. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
    Metra M, Nodari S, D'Aloia A, Madureri A, Rosselli F, Bontempi L, Zanini R, Dei Cas L.
    Eur Heart J; 1998 Feb 04; 19 Suppl B():B25-35. PubMed ID: 9519349
    [Abstract] [Full Text] [Related]

  • 9. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF, Miranda R, Verdejo HE, Greig D, Gabrielli LA, Alcaino H, Chiong M, Bustos C, Garcia L, Mellado R, Vukasovic JL, Godoy I, Lavandero S.
    J Heart Lung Transplant; 2008 Apr 04; 27(4):435-41. PubMed ID: 18374881
    [Abstract] [Full Text] [Related]

  • 10. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S, Dayi SU, Akbulut T, Dağ O, Köse H, Satiroğlu O, Sayar N, Bilsel T, Aksoy S, Yeşilçimen K.
    Anadolu Kardiyol Derg; 2003 Dec 04; 3(4):313-8. PubMed ID: 14675880
    [Abstract] [Full Text] [Related]

  • 11. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B, Kjörk E, Brunlöf G.
    Int J Cardiol; 2005 Oct 10; 104(3):257-63. PubMed ID: 16186053
    [Abstract] [Full Text] [Related]

  • 12. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
    Stawicki S, Roik M, Jasik M, Kosior D, Scisło P, Kochanowski J, Dembe K, Steckiewicz R, Karnafel W, Opolski G.
    Kardiol Pol; 2004 Nov 10; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
    [Abstract] [Full Text] [Related]

  • 13. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun 10; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 14. [The effect of physical training in chronic heart failure].
    Andersen K, Jónsdóttir S, Sigurethsson AF, Sigurethsson SB.
    Laeknabladid; 2006 Nov 10; 92(11):759-64. PubMed ID: 17093327
    [Abstract] [Full Text] [Related]

  • 15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 10; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 16. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
    Guazzi M, Pontone G, Trevisi N, Lomanto M, Melzi G, Agostoni P.
    Ann Ital Med Int; 1998 Feb 10; 13(1):17-23. PubMed ID: 9642838
    [Abstract] [Full Text] [Related]

  • 17. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD.
    Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004
    [Abstract] [Full Text] [Related]

  • 18. Long-term use of sildenafil in the therapeutic management of heart failure.
    Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2136-44. PubMed ID: 18036451
    [Abstract] [Full Text] [Related]

  • 19. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct 27; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 20. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr 27; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.